Viewing Study NCT05204160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-27 @ 11:44 PM
Study NCT ID: NCT05204160
Status: WITHDRAWN
Last Update Posted: 2024-07-03
First Post: 2022-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy
Sponsor: Emory University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-04-11
Start Date Type: ACTUAL
Primary Completion Date: 2024-02-27
Primary Completion Date Type: ACTUAL
Completion Date: 2024-02-27
Completion Date Type: ACTUAL
First Submit Date: 2022-01-11
First Submit QC Date: None
Study First Post Date: 2022-01-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-02
Last Update Post Date: 2024-07-03
Last Update Post Date Type: ACTUAL